The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Brenda W. Cooper

Department of Medicine

University Hospitals of Cleveland

Cleveland

OH 44106

USA

[email]@po.cwru.edu

Name/email consistency: medium

 
 
 
 
 
 
 

Affiliations

  • Department of Medicine, University Hospitals of Cleveland, Cleveland, OH 44106, USA. 2003 - 2006
  • Department of Medicine, Ireland Cancer Center, Case Western Reserve University, Cleveland, USA. 1998 - 2004

References

  1. Phase II study of dose-dense sequential doxorubicin and docetaxel for patients with advanced operable and inoperable breast cancer. Cooper, B.W., Radivoyevitch, T., Overmoyer, B.A., Shenk, R.R., Pham, H.T., Samuels, J.R., Parry, M.P., Silverman, P. Breast Cancer Res. Treat. (2006) [Pubmed]
  2. A phase I and pharmacodynamic study of fludarabine, carboplatin, and topotecan in patients with relapsed, refractory, or high-risk acute leukemia. Cooper, B.W., Veal, G.J., Radivoyevitch, T., Tilby, M.J., Meyerson, H.J., Lazarus, H.M., Koc, O.N., Creger, R.J., Pearson, G., Nowell, G.M., Gosky, D., Ingalls, S.T., Hoppel, C.L., Gerson, S.L. Clin. Cancer Res. (2004) [Pubmed]
  3. A phase I and pharmacodynamic study of sequential topotecan and etoposide in patients with relapsed or refractory acute myelogenous and lymphoblastic leukemia. Cooper, B.W., Donaher, E., Lazarus, H.M., Green, S.B., Gosky, D.M., Rosenthal, N.S., Berger, S.J., Li, X., Ingalls, S.T., Hoppel, C.L., Gerson, S.L. Leuk. Res. (2003) [Pubmed]
  4. Occult tumor contamination of hematopoietic stem-cell products does not affect clinical outcome of autologous transplantation in patients with metastatic breast cancer. Cooper, B.W., Moss, T.J., Ross, A.A., Ybanez, J., Lazarus, H.M. J. Clin. Oncol. (1998) [Pubmed]
 
WikiGenes - Universities